These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38978730)

  • 21. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
    Lee J; Kim TH; Kim GE; Keum KC; Kim YB
    J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy and safety of neoadjuvant chemotherapy with paclitaxel and cisplatin in combination with concurrent chemoradiotherapy for locally advanced cervical cancer: a systematic review and meta-analysis.
    Yeshe P; Li F
    J Radiat Res; 2024 Dec; 65(6):733-743. PubMed ID: 39373027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Neoadjuvant Chemotherapy on Lymph Node Metastasis of FIGO Stage IB1-IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
    Chen B; Wang L; Ren C; Shen H; Ding W; Zhu D; Mao L; Wang H
    Front Oncol; 2020; 10():570258. PubMed ID: 33251136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
    Li J; Li Y; Wang H; Shen L; Wang Q; Shao S; Shen Y; Xu H; Liu H; Cai R; Feng W
    BMC Cancer; 2023 Jan; 23(1):51. PubMed ID: 36641433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
    Pan XB; Lu Y; Wei YS; Yao DS
    BMC Cancer; 2024 Jan; 24(1):106. PubMed ID: 38238689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up.
    Wu SY; Wu YH; Yang MW; Hsueh WT; Hsiao JR; Tsai ST; Chang KY; Chang JS; Yen CJ
    BMC Cancer; 2014 Oct; 14():787. PubMed ID: 25351202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis.
    Liu H; Ma X; Sun C; Wu M; Xu Z; Zhou S; Yao N; Liu S; Qin X; Han Z
    Front Oncol; 2022; 12():997030. PubMed ID: 36568251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence.
    Matsuzaki S; Klar M; Mikami M; Shimada M; Grubbs BH; Fujiwara K; Roman LD; Matsuo K
    Curr Oncol Rep; 2020 Feb; 22(3):28. PubMed ID: 32052204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis.
    Marchetti C; Fagotti A; Tombolini V; Scambia G; De Felice F
    Cancer Treat Rev; 2020 Feb; 83():101945. PubMed ID: 31838220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.
    Chen YP; Guo R; Liu N; Liu X; Mao YP; Tang LL; Zhou GQ; Lin AH; Sun Y; Ma J
    J Cancer; 2015; 6(9):883-92. PubMed ID: 26284140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery.
    Sun H; Huang K; Tang F; Li X; Wang X; Long S; Zhou S; Suolangquzhen ; Zhang J; Ning R; Li S; Wang S; Ma D
    Sci Rep; 2018 Apr; 8(1):6443. PubMed ID: 29691415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the Role of Neoadjuvant Chemotherapy Followed by Surgery in Locally Advanced Cancer Cervix: A Meta-analysis of Phase III Trials.
    Osman MA
    J Obstet Gynaecol India; 2016 Oct; 66(5):352-7. PubMed ID: 27486281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis.
    Zhong L; Li K; Song L; Yin R
    J Obstet Gynaecol; 2022 Jul; 42(5):830-837. PubMed ID: 35148230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
    Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
    Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T
    Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
    Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age is a significant biomarker for the selection of neoadjuvant chemotherapy plus radiotherapy versus concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma.
    Lin Y; Yu X; Lu L; Chen H; Wu J; Chen Y; Lin Q; Wang X; Chen X; Chen X
    Cancer Biomark; 2023; 37(1):1-11. PubMed ID: 36938724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma.
    Yang S; Gao Y; Sun J; Xia B; Liu T; Zhang H; Li Q; Xiao M; Zhang Y
    Tumour Biol; 2015 Jun; 36(6):4349-56. PubMed ID: 25874487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
    Gong L; Lou JY; Wang P; Zhang JW; Liu H; Peng ZL
    Int J Gynaecol Obstet; 2012 Apr; 117(1):23-6. PubMed ID: 22265255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.
    Xu Y; Zhang M; Zhang J; Ng DM; Chen X; Si Y; Shi Y; Li X; Mao D; Yang L
    Taiwan J Obstet Gynecol; 2021 May; 60(3):433-441. PubMed ID: 33966724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.